DalsnaFinance

Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Markets GlobeNewswire By GlobeNewswire 29 Jul 2026 14:00 1 min read
Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation

Smith+Nephew’s TESSA Spatial Surgery System granted De Novo classification by the FDA; a generational leap in Sports Medicine for personalized planning

Smith+Nephew’s TESSA Spatial Surgery System granted De Novo classification by the FDA; a generational leap in Sports Medicine for personalized planning

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.